Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19

Affiliations

• ¹ Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA. Electronic address: bbikdeli@bwh.harvard.edu.
• ² Division of Cardiovascular Medicine, Long Island Jewish Medical Center, Northwell Health, Zucker School of Medicine, New Hyde Park, New York, USA. Electronic address: https://twitter.com/SauravChMD.
• ³ Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio, USA.
• ⁴ Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universidad Católica San Antonio de Murcia, Barcelona, Spain. Electronic address: https://twitter.com/mmonrealriete.
• ⁵ Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain. Electronic address: https://twitter.com/DJC6998.
• ⁶ Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut, USA. Electronic address: https://twitter.com/hmkyale.
• ⁷ Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
• ⁸ Department of Neurology, Vagelos College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA. Electronic address: https://twitter.com/MitchElkind.